Q46619788: Difference between revisions
Created claim: main subject (P921): patient (Q181600), #quickstatements; batch #6366 by User:Daniel Mietchen |
Set a claim value: title (P1476): Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group |
||||||||||||||
(10 intermediate revisions by 7 users not shown) | |||||||||||||||
label / en | label / en | ||||||||||||||
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group | Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group | ||||||||||||||
label / nl | label / nl | ||||||||||||||
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group | Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group | ||||||||||||||
description / uk | description / uk | ||||||||||||||
наукова стаття | наукова стаття, опублікована в травні 2008 | ||||||||||||||
Property / title | Property / title | ||||||||||||||
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group (English) | |||||||||||||||
Property / author name string | |||||||||||||||
Property / author name string: F Stephen Hodi / rank | |||||||||||||||
Property / author name string: F Stephen Hodi / qualifier | |||||||||||||||
Property / author name string: F Stephen Hodi / reference | |||||||||||||||
PubMed publication ID: 18445842 retrieved: 23 December 2017
reference URL: http://europepmc.org/abstract/MED/18445842 | |||||||||||||||
Property / main subject | |||||||||||||||
Property / main subject: dacarbazine / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / main subject: dacarbazine / reference | |||||||||||||||
Property / language of work or name | |||||||||||||||
Property / language of work or name: English / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: F Stephen Hodi / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author: F Stephen Hodi / qualifier | |||||||||||||||
Property / author: F Stephen Hodi / qualifier | |||||||||||||||
object named as: F Stephen Hodi | |||||||||||||||
Property / author: F Stephen Hodi / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 18445842 retrieved: 23 December 2017
reference URL: http://europepmc.org/abstract/MED/18445842 | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Mutations of the BRAF gene in human cancer / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work: Mutations of the BRAF gene in human cancer / reference | |||||||||||||||
stated in: COCI retrieved: 24 May 2022
reference URL: https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE00766 | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Systemic treatments for metastatic cutaneous melanoma. / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work: Systemic treatments for metastatic cutaneous melanoma. / reference | |||||||||||||||
stated in: COCI retrieved: 30 December 2023
reference URL: https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001215 |